Health Day correspondent
Friday, July 16, 2021 (Healthday News) – Pfizer Inc. agrees to pay 45 345 million in proposed settlement to resolve steep lawsuits EpiPen The price goes up.
In 2016, Pfizer and its subsidiaries, Meridian Medical Technologies Inc. and King Pharmaceuticals, filed several class-action lawsuits alleging that they engaged in adverse conduct related to EpiPen. The Associated Press Reported.
Another company that is the defendant in the lawsuit is Mylan, which owns the Epigen brand, even though the devices are manufactured by Pfizer.
Mylan acquired the right to sell and distribute the equipment in 2007 when the EpiPen package cost about $ 100. Now, it costs 50 650 more without pharmacy coupons or manufacturer discounts AP Reported.
Kansas City’s NPR station said court documents filed Thursday in Kansas City’s federal court have asked Pfizer and its two affiliates to approve the settlement. KCUR-FM.
Three weeks ago, most of the claims against Mylan were dismissed, but the judge allowed the trial proceedings to be filed against the company, beginning September 7 AP Reported.
Plaintiffs’ lawyer, Rex Sharp, said his clients were pleased that Pfizer had agreed to the complaint, which still required court approval AP Reported
In an email to KCUR-FM, a Pfizer spokesperson denied any wrongdoing by the company and said the settlement had been attempted to “avoid the burden of continued litigation and to focus on the progress that would change the lives of patients.”
The National Institute of Allergy and Infectious Diseases has more Food allergies.
Source: Associated Press